{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:54:46Z","timestamp":1781463286954,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","painmanagementnursing.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pain Management Nursing"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.pmn.2025.06.010","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:17:05Z","timestamp":1753355825000},"page":"e17-e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cannabis Use for Chronic Pain in Sickle Cell Disease: A Scoping Review"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8229-0677","authenticated-orcid":false,"given":"Simone B.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Payton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8117-3445","authenticated-orcid":false,"given":"Keesha","family":"Powell-Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7168-0144","authenticated-orcid":false,"given":"Angela","family":"Starkweather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7770-3754","authenticated-orcid":false,"given":"Robert L.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepthi S.","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen L.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-1335","authenticated-orcid":false,"given":"Staja Q.","family":"Booker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.pmn.2025.06.010_bib0001","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.10874","article-title":"Effect of inhaled cannabis for pain in adults with sickle cell disease: A randomized clinical trial","volume":"3","author":"Abrams","year":"2020","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.pmn.2025.06.010_bib0002","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/08971900221128335","article-title":"Rates of opioid misuse amongst patients receiving pain management for sickle cell disease in an urban setting","volume":"37","author":"Ahmed","year":"2024","journal-title":"Journal of Pharmacy Practice"},{"key":"10.1016\/j.pmn.2025.06.010_bib0003","year":"2023","journal-title":"ANA officially recognizes cannabis nursing as a specialty nursing practice"},{"key":"10.1016\/j.pmn.2025.06.010_bib0004","year":"2024","journal-title":"Cannabis nursing: Scope and standards of practice"},{"key":"10.1016\/j.pmn.2025.06.010_bib0005","year":"2024","journal-title":"ANA applauds HHS recommendation to reconsider marijuana\u2019s drug classification"},{"issue":"12","key":"10.1016\/j.pmn.2025.06.010_bib0006","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.3390\/jcm9123902","article-title":"Considerations for cannabis use to treat pain in sickle cell disease","volume":"9","author":"Argueta","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"2","key":"10.1016\/j.pmn.2025.06.010_bib0007","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/can.2022.0136","article-title":"Effects of medical cannabis certification on hospital use by individuals with sickle cell disease","volume":"9","author":"Aron","year":"2024","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"1","key":"10.1016\/j.pmn.2025.06.010_bib0009","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/can.2017.0011","article-title":"The use of cannabis by patients with sickle cell disease increased the frequency of hospitalization due to vaso-occlusive crises","volume":"2","author":"Ballas","year":"2017","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"12","key":"10.1016\/j.pmn.2025.06.010_bib0010","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American society of hematology 2020 guidelines for sickle cell disease: Management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Advances"},{"issue":"3","key":"10.1016\/j.pmn.2025.06.010_bib0011","first-page":"180","article-title":"Medicinal cannabis: History, pharmacology, and implications for the acute care setting","volume":"42","author":"Bridgeman","year":"2017","journal-title":"P & T: A Peer-Reviewed Journal for Formulary Management"},{"issue":"4","key":"10.1016\/j.pmn.2025.06.010_bib0014","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/15265161.2019.1567193","article-title":"Why insurance companies should pay for medical cannabis","volume":"19","author":"Casarett","year":"2019","journal-title":"The American Journal of Bioethics: AJOB"},{"key":"10.1016\/j.pmn.2025.06.010_bib0013","unstructured":"Covidence. (n.d.). Covidence systematic review software. Veritas Health Innovation. Available at www.covidence.org"},{"key":"10.1016\/j.pmn.2025.06.010_bib0016","unstructured":"Critical Appraisal Skills Programme (CASP). (2018). CASP qualitative checklist. Retrieved from https:\/\/casp-uk.net\/casp-tools-checklists\/ Accessed from: March 1, 2024."},{"issue":"3","key":"10.1016\/j.pmn.2025.06.010_bib0017","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/can.2019.0036","article-title":"Daily cannabis users with sickle cell disease show fewer admissions than others with similar pain complaints","volume":"5","author":"Curtis","year":"2020","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"16","key":"10.1016\/j.pmn.2025.06.010_bib0018","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1182\/bloodadvances.2020002325","article-title":"Medical marijuana certification for patients with sickle cell disease: A report of a single center experience","volume":"4","author":"Curtis","year":"2020","journal-title":"Blood Advances"},{"issue":"1","key":"10.1016\/j.pmn.2025.06.010_bib0019","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"De Gregorio","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.pmn.2025.06.010_bib0020","unstructured":"Drug Enforcement Agency. (2024). Schedules of controlled substances: Rescheduling of marijuana. https:\/\/www.federalregister.gov\/documents\/2024\/08\/29\/2024-19370\/schedules-of-controlled-substances-rescheduling-of-marijuana, Accessed March 1, 2024."},{"issue":"2","key":"10.1016\/j.pmn.2025.06.010_bib0021","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/papr.12841","article-title":"A qst-based pain phenotype in adults with sickle cell disease: Sensitivity and specificity of quality descriptors","volume":"20","author":"Dyal","year":"2020","journal-title":"Pain Practice: The Official Journal of World Institute of Pain"},{"issue":"4","key":"10.1016\/j.pmn.2025.06.010_bib0022","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s40122-022-00434-5","article-title":"Systematic review and meta-analysis seem to indicate that cannabinoids for chronic primary pain treatment have limited benefit","volume":"11","author":"Giossi","year":"2022","journal-title":"Pain and Therapy"},{"key":"10.1016\/j.pmn.2025.06.010_bib0023","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.pmn.2025.06.010_bib0024","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2141.2005.05723.x","article-title":"Cannabis use in sickle cell disease: A questionnaire study","volume":"131","author":"Howard","year":"2005","journal-title":"British Journal of Haematology"},{"issue":"Suppl 1","key":"10.1016\/j.pmn.2025.06.010_bib0025","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/geroni\/igad104.2805","article-title":"Two sides of the same coin: Opioids and cannabis for pain management in African American older adults","volume":"7","author":"Jackson","year":"2023","journal-title":"Innovation in Aging"},{"issue":"22","key":"10.1016\/j.pmn.2025.06.010_bib0027","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1182\/blood.V128.22.5913.5913","article-title":"The use of marijuana and hydroxyurea among sickle cell patients","volume":"128","author":"Kalu","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pmn.2025.06.010_bib0029","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: A review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.pmn.2025.06.010_bib0030","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1089\/can.2021.0061","article-title":"Ask tour provider about cannabis: Increasing nurse practitioner knowledge and onfidence","volume":"7","author":"Klein","year":"2022","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"4","key":"10.1016\/j.pmn.2025.06.010_bib0031","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1590\/S0043-31442006000400004","article-title":"The prevalence of marijuana smoking in young adults with sickle cell disease: A longitudinal study","volume":"55","author":"Knight-Madden","year":"2006","journal-title":"West Indian Medical Journal"},{"issue":"3","key":"10.1016\/j.pmn.2025.06.010_bib0032","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2010-01-260372","article-title":"Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: Modulation by cannabinoids","volume":"116","author":"Kohli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pmn.2025.06.010_bib0033","article-title":"Opioid prescribing. StatPearls","author":"Kopitnik","year":"2024","journal-title":"StatPearls Publishing"},{"issue":"7","key":"10.1016\/j.pmn.2025.06.010_bib0034","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/AJP.0000000000001119","article-title":"Adolescents and young adults with sickle cell disease: Nociplastic pain and pain catastrophizing as predictors of pain interference and opioid consumption","volume":"39","author":"Kuisell","year":"2023","journal-title":"The Clinical Journal of Pain"},{"issue":"6","key":"10.1016\/j.pmn.2025.06.010_bib0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bpsc.2020.07.016","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biological Psychiatry. Cognitive Neuroscience and Neuroimaging"},{"issue":"2","key":"10.1016\/j.pmn.2025.06.010_bib0036","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/exd.14256","article-title":"A new treatment paradigm for sickle cell disease leg ulcers: Topical cannabis-based medicines","volume":"30","author":"Maida","year":"2021","journal-title":"Experimental Dermatology"},{"key":"10.1016\/j.pmn.2025.06.010_bib0037","series-title":"StatPearls","article-title":"Sickle cell anemia","author":"Mangla","year":"2023"},{"key":"10.1016\/j.pmn.2025.06.010_bib0039","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-204199","article-title":"Priapism in a patient with sickle cell trait using marijuana","author":"Matta","year":"2014","journal-title":"BMJ Case Reports"},{"key":"10.1016\/j.pmn.2025.06.010_bib0040","article-title":"Weeding through the information: Interpreting laboratory tests to determine new vs. residual use of marijuana","year":"2022","journal-title":"Mayo Clinic"},{"issue":"2","key":"10.1016\/j.pmn.2025.06.010_bib0041","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/jwh.2006.15.146","article-title":"Gender differences in pain and healthcare utilization for adult sickle cell patients: The pisces project","volume":"15","author":"McClish","year":"2006","journal-title":"Journal of Women\u2019s Health"},{"issue":"Supplement 1","key":"10.1016\/j.pmn.2025.06.010_bib0042","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood-2018-99-118163","article-title":"Clinical characteristics and health care utilization patterns of sickle cell disease patients using marijuana","volume":"132","author":"Miodownik","year":"2018","journal-title":"Blood"},{"issue":"9-10","key":"10.1016\/j.pmn.2025.06.010_bib0043","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jpain.2019.11.002","article-title":"Sensitivities to thermal and mechanical stimuli: Adults with sickle cell disease compared to healthy, pain-free african american controls","volume":"21","author":"Molokie","year":"2020","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.pmn.2025.06.010_bib0044","series-title":"The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research","article-title":"Health and Medicine Division, Board on Population Health and Public Health Practice, & Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda","year":"2017"},{"key":"10.1016\/j.pmn.2025.06.010_bib0045","series-title":"Sickle cell disease. National Institutes of Health","year":"2024"},{"issue":"5","key":"10.1016\/j.pmn.2025.06.010_bib0046","article-title":"The efficacy of marijuana use for pain relief in adults with sickle cell disease: A systematic review","volume":"14","author":"Paulsingh","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.pmn.2025.06.010_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.921493","article-title":"Potency and therapeutic THC and CBD ratios: U.S. cannabis markets overshoot","volume":"13","author":"Pennypacker","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"10.1016\/j.pmn.2025.06.010_bib0048","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/0193945919836446","article-title":"Neuropathic pain screening: Construct validity in patients with sickle cell disease","volume":"42","author":"Powell-Roach","year":"2020","journal-title":"Western Journal of Nursing Research"},{"issue":"1","key":"10.1016\/j.pmn.2025.06.010_bib0049","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/can.2018.0001","article-title":"Marijuana use in adults living with sickle cell disease","volume":"3","author":"Roberts","year":"2018","journal-title":"Cannabis and Cannabinoid Research"},{"key":"10.1016\/j.pmn.2025.06.010_bib0052","series-title":"StatPearls","article-title":"Cannabinoids","author":"Sheikh","year":"2023"},{"key":"10.1016\/j.pmn.2025.06.010_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104087","article-title":"Chronic pain management in sickle cell disease: A systematic scoping review of controlled trials","volume":"190","author":"Sidhom","year":"2023","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"5","key":"10.1016\/j.pmn.2025.06.010_bib0051","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4410","article-title":"Management of chronic pain in adults living with sickle cell disease in the era of the opioid epidemic: A qualitative study","volume":"2","author":"Sinha","year":"2019","journal-title":"JAMA Network Open"},{"issue":"2","key":"10.1016\/j.pmn.2025.06.010_bib0053","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pmn.2025.06.010_bib0054","article-title":"Precision, integrative medicine for pain management in sickle cell disease","volume":"4","author":"Smith","year":"2023","journal-title":"Frontiers in Pain Research (Lausanne, Switzerland)"},{"issue":"7","key":"10.1016\/j.pmn.2025.06.010_bib0055","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pmn.2025.06.010_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2021.816747","article-title":"Cannabinoids in chronic pain: Therapeutic potential through microglia modulation","volume":"15","author":"van den Hoogen","year":"2022","journal-title":"Frontiers in Neural Circuits"},{"key":"10.1016\/j.pmn.2025.06.010_bib0057","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2000"},{"issue":"7","key":"10.1016\/j.pmn.2025.06.010_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235192","article-title":"Marijuana use and health behaviors in a US clinic sample of patients with sickle cell disease","volume":"15","author":"Wilson","year":"2020","journal-title":"PloS one"},{"issue":"4","key":"10.1016\/j.pmn.2025.06.010_bib0060","first-page":"923","article-title":"Cannabinoids ameliorate pain and reduce disease pathology in ceramide-induced sickle cell disease mouse model","volume":"25","author":"Zhang","year":"2021","journal-title":"European Journal of Pain"},{"issue":"6","key":"10.1016\/j.pmn.2025.06.010_bib62","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ajad.13456","article-title":"Daily cannabis use may cause cannabis-induced hyperalgesia","volume":"32","author":"Zhang-James","year":"2023","journal-title":"The American journal on addictions"},{"issue":"3","key":"10.1016\/j.pmn.2025.06.010_bib0058","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/03630269.2016.1149077","article-title":"Sickle cell crisis complicated by synthetic cannabinoid abuse: A case report","volume":"40","author":"Zheng","year":"2016","journal-title":"Hemoglobin"},{"issue":"3","key":"10.1016\/j.pmn.2025.06.010_bib0059","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"International Journal of Molecular Sciences"}],"container-title":["Pain Management Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1524904225002012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1524904225002012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:06:23Z","timestamp":1781460383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1524904225002012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1524904225002012"],"URL":"https:\/\/doi.org\/10.1016\/j.pmn.2025.06.010","relation":{},"ISSN":["1524-9042"],"issn-type":[{"value":"1524-9042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabis Use for Chronic Pain in Sickle Cell Disease: A Scoping Review","name":"articletitle","label":"Article Title"},{"value":"Pain Management Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pmn.2025.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pain Management Nursing. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}